In transit metastases in children, adolescents and young adults with localized rhabdomyosarcoma of the distal extremities : Analysis of the EpSSG RMS 2005 study
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved..
In-transit metastases (ITM) are defined as metastatic lymph nodes or deposits occurring between the primary tumor and proximal draining lymph node basin. In extremity rhabdomyosarcoma (RMS), they have rarely been reported. This study evaluates the frequency, staging and survival of patients with ITM in distal extremity RMS.
METHODS: Patients with extremity RMS distal to the elbow or knee, enrolled in the EpSSG RMS 2005 trial between 2005 and 2016 were eligible for this study.
RESULTS: One hundred and nine distal extremity RMS patients, with a median age of 6.2 years (range 0-21 years) were included. Thirty seven of 109 (34%) had lymph node metastases at diagnosis, 19 of them (51%) had ITM, especially in lower extremity RMS. 18F-FDG-PET/CT detected involved lymph nodes in 47% of patients. In patients not undergoing 18F-FDG-PET/CT lymph node involvement was detected in 22%. The 5-yr EFS of patients with ITM vs proximal lymph nodes vs combined proximal and ITM was 88.9% vs 21.4% vs 20%, respectively (p = 0.01) and 5-yr OS was 100% vs 25.2% vs 15%, respectively (p = 0.003).
CONCLUSION: Our study showed that in-transit metastases constituted more than 50% of all lymph node metastases in distal extremity RMS. 18F-FDG-PET/CT improved nodal staging by detecting more regional and in-transit metastases. Popliteal and epitrochlear nodes should be considered as true (distal) regional nodes, instead of in-transit metastases. Biopsy of these nodes is recommended especially in distal extremity RMS of the lower limb. Patients with proximal (axillary or inguinal) lymph node involvement have a worse prognosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 48(2022), 7 vom: 06. Juli, Seite 1536-1542 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Terwisscha van Scheltinga, C E J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
0Z5B2CJX4D |
|---|
| Anmerkungen: |
Date Completed 28.06.2022 Date Revised 21.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ejso.2022.03.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM338377670 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM338377670 | ||
| 003 | DE-627 | ||
| 005 | 20231226000532.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejso.2022.03.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1127.xml |
| 035 | |a (DE-627)NLM338377670 | ||
| 035 | |a (NLM)35307252 | ||
| 035 | |a (PII)S0748-7983(22)00123-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Terwisscha van Scheltinga, C E J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a In transit metastases in children, adolescents and young adults with localized rhabdomyosarcoma of the distal extremities |b Analysis of the EpSSG RMS 2005 study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.06.2022 | ||
| 500 | |a Date Revised 21.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved. | ||
| 520 | |a In-transit metastases (ITM) are defined as metastatic lymph nodes or deposits occurring between the primary tumor and proximal draining lymph node basin. In extremity rhabdomyosarcoma (RMS), they have rarely been reported. This study evaluates the frequency, staging and survival of patients with ITM in distal extremity RMS | ||
| 520 | |a METHODS: Patients with extremity RMS distal to the elbow or knee, enrolled in the EpSSG RMS 2005 trial between 2005 and 2016 were eligible for this study | ||
| 520 | |a RESULTS: One hundred and nine distal extremity RMS patients, with a median age of 6.2 years (range 0-21 years) were included. Thirty seven of 109 (34%) had lymph node metastases at diagnosis, 19 of them (51%) had ITM, especially in lower extremity RMS. 18F-FDG-PET/CT detected involved lymph nodes in 47% of patients. In patients not undergoing 18F-FDG-PET/CT lymph node involvement was detected in 22%. The 5-yr EFS of patients with ITM vs proximal lymph nodes vs combined proximal and ITM was 88.9% vs 21.4% vs 20%, respectively (p = 0.01) and 5-yr OS was 100% vs 25.2% vs 15%, respectively (p = 0.003) | ||
| 520 | |a CONCLUSION: Our study showed that in-transit metastases constituted more than 50% of all lymph node metastases in distal extremity RMS. 18F-FDG-PET/CT improved nodal staging by detecting more regional and in-transit metastases. Popliteal and epitrochlear nodes should be considered as true (distal) regional nodes, instead of in-transit metastases. Biopsy of these nodes is recommended especially in distal extremity RMS of the lower limb. Patients with proximal (axillary or inguinal) lymph node involvement have a worse prognosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Extremity | |
| 650 | 4 | |a In-transit metastases | |
| 650 | 4 | |a Lymph nodes | |
| 650 | 4 | |a Pediatric | |
| 650 | 4 | |a Rhabdomyosarcoma | |
| 650 | 7 | |a Fluorodeoxyglucose F18 |2 NLM | |
| 650 | 7 | |a 0Z5B2CJX4D |2 NLM | |
| 700 | 1 | |a Wijnen, M H W A |e verfasserin |4 aut | |
| 700 | 1 | |a Martelli, H |e verfasserin |4 aut | |
| 700 | 1 | |a Guerin, F |e verfasserin |4 aut | |
| 700 | 1 | |a Rogers, T |e verfasserin |4 aut | |
| 700 | 1 | |a Craigie, R J |e verfasserin |4 aut | |
| 700 | 1 | |a Burrieza, G Guillén |e verfasserin |4 aut | |
| 700 | 1 | |a Dall'Igna, P |e verfasserin |4 aut | |
| 700 | 1 | |a De Corti, F |e verfasserin |4 aut | |
| 700 | 1 | |a Smeulders, N |e verfasserin |4 aut | |
| 700 | 1 | |a van Rijn, R R |e verfasserin |4 aut | |
| 700 | 1 | |a Fajardo, R Dávila |e verfasserin |4 aut | |
| 700 | 1 | |a Mandeville, H C |e verfasserin |4 aut | |
| 700 | 1 | |a Zanetti, I |e verfasserin |4 aut | |
| 700 | 1 | |a Coppadoro, B |e verfasserin |4 aut | |
| 700 | 1 | |a Minard-Colin, V |e verfasserin |4 aut | |
| 700 | 1 | |a Jenney, M |e verfasserin |4 aut | |
| 700 | 1 | |a Bisogno, G |e verfasserin |4 aut | |
| 700 | 1 | |a van Noesel, M M |e verfasserin |4 aut | |
| 700 | 1 | |a van der Steeg, A F W |e verfasserin |4 aut | |
| 700 | 1 | |a Merks, J H M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology |d 1993 |g 48(2022), 7 vom: 06. Juli, Seite 1536-1542 |w (DE-627)NLM01262862X |x 1532-2157 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2022 |g number:7 |g day:06 |g month:07 |g pages:1536-1542 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejso.2022.03.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2022 |e 7 |b 06 |c 07 |h 1536-1542 | ||